Ledger.Open graph →
SEC Form D · filed June 28, 2017

Axon Therapies Inc

Offering
$2.0M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Other Technology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Mark R. Gelfand · New York, NYExecPaul S. Laviolette · New York, NYDirectorMitchell S. Bloom · New York, NYExecHoward R. Levin · New York, NYExec · DirectorWadstrom Nicolai · San Francisco, CAExec · DirectorBenjamin Levy · San Francisco, CAExecCarl J. Tippit · Cleveland, OHExecBradley M. Anderson · New York, NYDirectorDavid Dunn · Wilton, CTDirectorNicolai Wadstrom · San Francisco, CAExec · DirectorRagan Young · Dallas, TXExecRobert A. Granieri · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗